AcuityMD, which offers a health data tool for the medical technology industry, announced it secured $45 million in funding, bringing its total raise to more than $83 million.
ICONIQ Growth led the round, with participation from Stepstone Group, Atreides Management, Benchmark Capital, Artisanal Ventures and Redpoint Ventures.
The Boston-based company’s platform combines medical device data from sales to patient outcomes so manufacturers can track the performance of their products.
The company will use the funds to expand its product’s reach with MedTech manufacturers.
“We are fortunate to work with fantastic financial partners as well as experienced MedTech industry executives who broaden the perspective of our Customer Advisory Board,” Michael Monovoukas, CEO and cofounder of AcuityMD, said in a statement.
“With this additional capital, we aim to launch three new products to general availability, expand our pipeline management solution to more customers and grow our engineering and product teams by 70% by the end of 2024 to support our mission of accelerating the adoption of cutting-edge medical technology.”
Digital heart and lung disease health startup Eko Health announced it raised $41 million in Series D financing.
ARTIS Ventures, NTTVC, Questa Capital and Highland Capital Partners participated in the round.
California-based Eko Health combines ECG-enabled digital stethoscope devices with monitoring and analysis algorithms to help providers detect heart rhythm abnormalities and other heart and lung diseases.
The company will use the funds to scale access to its early disease detection platform globally.
“Just as Ring transformed doorbells into home security systems, Eko has reinvented the world’s most ubiquitous medical tool into a powerful early disease detection platform, creating the world’s largest install base of professional AI-enabled cardiology devices,” Connor Landgraf, CEO and cofounder of Eko Health, said in a statement.
Publisher: Source link
